Could an AI Diagnosis Be Better Than a Human’s?
In this month's issue: AI diagnosis vs. a human's, the American Academy of Ophthalmology joins Figure 1, and 72% of healthcare professionals didn't know this answer.
Could an AI Diagnosis Be Better Than a Human’s? Here's What Over 700 Figure 1 Members Had to Say ...
With artificial intelligence technology becoming more advanced year after year, this question of if AI could take over human jobs has begun to creep into more knowledge-based industries, like healthcare. One?interesting study tested the performance of the AI language model, ChatGPT, on the United States Medical Licensing Exam (USMILE).
Amazingly, the model passed all three sections of the exam, although it did so with slim margins. However, what is most significant about this study is that this was a new language model, launched only two months before completing the exam. Furthermore, it had not been trained on any biomedical data. Essentially, it passed without studying.?
This shows enormous potential for AI-assisted education and perhaps even the ability to provide patients an accurate AI diagnosis. However, it also begs the question, could AI become better at diagnosing than a human healthcare professional? With this in mind, we asked the Figure 1 community for their thoughts on AI in healthcare.
American Academy of Ophthalmology Joins Figure 1
The American Academy of Ophthalmology, the world’s largest association of eye physicians and surgeons, is now sharing medical cases to Figure 1.
领英推荐
How do you make a reliable diagnosis of a bleeding disorder secondary to an underlying condition?
72% of healthcare professionals didn't know.
We recently tested the Figure 1 community on bleeding disorders. In one case, a 60-year-old, with a previous spontaneous hematoma of the left hip and ankle, presented with bloody bowel movements. Imaging showed hepatomegaly with heterogeneous enhancement of the liver parenchyma. Liver biopsy and genetic tests revealed morphological, immunophenotypically, and molecular-genetic characteristics of low-grade angiosarcoma of the liver. Our question asked, in the setting of hepatic angiosarcoma, what’s the most likely lab indicator of possible disseminated intravascular coagulation?
A majority of respondents (72%) incorrectly chose fibrinogen ≤1.0 g/L (31%), prothrombin time ≥6 s (21%), or platelet count <50 ×109/L (20%). Only 28% of respondents chose the correct answer, fibrin markers ≥5x upper limit of normal.
There is clearly work to be done to educate healthcare professionals on this topic. Does your organization focus on bleeding disorders?
About Figure 1
Figure 1?is the world’s leading platform for medical case-based knowledge sharing and collaboration, and a winner of the Webby People’s Voice Award for Best App in the Experimental & Innovation category. With over 3 million registered members in 190 countries worldwide, the platform allows verified healthcare professionals of all kinds — from physicians and medical students, to nurse practitioners and physician assistants — to safely and securely collaborate on cases to lower costs and improve patient outcomes.
Want to work with Figure 1??Contact us >